Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:Q9ULH0 KIDINS220

Class:IdReferenceGeneProduct:219182
_chainChangeLogchain:1-1771 added on Fri February 6 2015
_displayNameUniProt:Q9ULH0 KIDINS220
_timestamp2026-02-20 21:31:19
chainchain:1-1771
checksumFD1F99DB88B6996D
commentFUNCTION Promotes a prolonged MAP-kinase signaling by neurotrophins through activation of a Rap1-dependent mechanism. Provides a docking site for the CRKL-C3G complex, resulting in Rap1-dependent sustained ERK activation. May play an important role in regulating postsynaptic signal transduction through the syntrophin-mediated localization of receptor tyrosine kinases such as EPHA4. In cooperation with SNTA1 can enhance EPHA4-induced JAK/STAT activation. Plays a role in nerve growth factor (NGF)-induced recruitment of RAPGEF2 to late endosomes and neurite outgrowth. May play a role in neurotrophin- and ephrin-mediated neuronal outgrowth and in axon guidance during neural development and in neuronal regeneration (By similarity). Modulates stress-induced apoptosis of melanoma cells via regulation of the MEK/ERK signaling pathway.SUBUNIT Found in a complex, at least composed of KIDINS220, MAGI2, NTRK1 and RAPGEF2; the complex is mainly formed at late endosomes in a nerve growth factor (NGF)-dependent manner. Interacts with RAPGEF2; the interaction is strengthened after NGF stimulation. Isoform 2 interacts (via C-terminal domain) with MAGI2 isoform 1 (via PDZ domain). Interacts with NTRK1, NTRK2, NTRK3, ERKL and NGFR. Can form a ternary complex with NGFR and NTRK1 and this complex is affected by the expression levels of KIDINS220/ARMS. An increase in KIDINS220/ARMS expression leads to a decreased association of NGFR and NTRK1. Interacts (via PDZ-binding motif) with SNTA1 and SNTB2 (via PDZ domains). Interacts with EPHA4 and PRKD1.INTERACTION Localized at late endosome before or after nerve growth factor (NGF) stimulation.ALTERNATIVE PRODUCTS Abundant in developing and adult neural tissues as well as neuroendocrine cells and dendritic cells. Overexpressed in melanoma and melanoma cell lines.DOMAIN The transmembrane domain mediates interaction with NTRK1.PTM Tyrosine phosphorylated by NTRK1, NTRK2, EPHB2 and EPHA4. Phosphorylation at Ser-918 is induced by phorbol ester treatment. Phosphorylation by NTRK2 is induced by brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5. Phosphorylation by NTRK1 is induced by nerve growth factor (NGF) (By similarity).DISEASE The disease is caused by variants affecting the gene represented in this entry.DISEASE The disease is caused by variants affecting the gene represented in this entry.
created[InstanceEdit:217385] Schmidt, EE, 2008-03-27 06:23:53
descriptionrecommendedName: Kinase D-interacting substrate of 220 kDa alternativeName: Ankyrin repeat-rich membrane-spanning protein
geneNameKIDINS220
ARMS
KIAA1250
identifierQ9ULH0
isSequenceChangedFALSE
keyword3D-structure
Alternative splicing
ANK repeat
Disease variant
Endosome
Hereditary spastic paraplegia
Intellectual disability
Membrane
Neurodegeneration
Neurogenesis
Obesity
Phosphoprotein
Proteomics identification
Reference proteome
Repeat
Transmembrane
Transmembrane helix
modified[InstanceEdit:9836292] Weiser, Joel, 2023-05-25
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
[InstanceEdit:9983091] Weiser, Joel, 2026-02-20
nameKIDINS220
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:8989021] ENSEMBL:ENSG00000134313 KIDINS220 [Homo sapiens]
secondaryIdentifierKDIS_HUMAN
A1L4N4
Q4VC08
Q6MZU2
Q9H889
Q9H9E4
Q9NT37
Q9UF42
sequenceLength1771
species[Species:48887] Homo sapiens
(isoformParent)[ReferenceIsoform:219183] UniProt:Q9ULH0-2 KIDINS220 [Homo sapiens]
[ReferenceIsoform:219184] UniProt:Q9ULH0-3 KIDINS220 [Homo sapiens]
[ReferenceIsoform:219185] UniProt:Q9ULH0-4 KIDINS220 [Homo sapiens]
[ReferenceIsoform:219186] UniProt:Q9ULH0-5 KIDINS220 [Homo sapiens]
[ReferenceIsoform:415495] UniProt:Q9ULH0-1 KIDINS220 [Homo sapiens]
(referenceEntity)[EntityWithAccessionedSequence:169869] p-Y1095-KIDINS220 [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:169880] KIDINS220 [cytosol] [Homo sapiens]
(referenceSequence)[ModifiedResidue:169859] O4'-phospho-L-tyrosine at 1095
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:Q9ULH0 KIDINS220 (219182)